Search Results - Loic Verlingue

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    A prospective pragmatic evaluation of automatic trial matching tools in a molecular tumor board by Lilia Gueguen, Louise Olgiati, Clément Brutti-Mairesse, Alric Sans, Vincent Le Texier, Loic Verlingue

    Published in npj Precision Oncology (2025-01-01)
    Get full text
    Article


  2. 2

    Artificial intelligence in oncology: ensuring safe and effective integration of language models in clinical practice by Loïc Verlingue, Clara Boyer, Louise Olgiati, Clément Brutti Mairesse, Daphné Morel, Jean-Yves Blay

    Published in The Lancet Regional Health. Europe (2024-11-01)
    Get full text
    Article


  3. 3

    The French multicentric molecular analysis platforms and personalized medicine trials MOST, MOST Plus and MEGAMOST by Loic Verlingue, Marine Desevre, Marie Polito, Gwenaelle Garin, Christine Rodriguez, Wang Qing, Olivier Tredan, David Perol, Isabelle Ray-Coquard, Sylvie Chabaud, Jean Yves Blay

    Published in Acta Oncologica (2024-05-01)
    Get full text
    Article


  4. 4

    An international phase II trial and immune profiling of SBRT and atezolizumab in advanced pretreated colorectal cancer by Antonin Levy, Daphné Morel, Matthieu Texier, Roger Sun, Jerome Durand-Labrunie, Maria E Rodriguez-Ruiz, Severine Racadot, Stéphane Supiot, Nicolas Magné, Stacy Cyrille, Guillaume Louvel, Christophe Massard, Loic Verlingue, Fanny Bouquet, Alberto Bustillos, Lisa Bouarroudj, Clément Quevrin, Céline Clémenson, Michele Mondini, Lydia Meziani, Lambros Tselikas, Rastilav Bahleda, Antoine Hollebecque, Eric Deutsch

    Published in Molecular Cancer (2024-03-01)
    Get full text
    Article


  5. 5

    Phase 2 study of the antitumour activity and safety of simlukafusp alfa (FAP-IL2v) combined with atezolizumab in patients with recurrent and/or metastatic cervical squamous cell ca... by Loic Verlingue, Antoine Italiano, Hans Prenen, Eva Maria Guerra Alia, Diego Tosi, Ruth Perets, Iwona Lugowska, Vladimir Moiseyenko, Mahmut Gumus, Cagatay Arslan, Colin R. Lindsay, Sanjeev Deva, Álvaro Taus, Ana Oaknin, Sylvie Rottey, Irfan Cicin, Sema Sezgin Goksu, Alexey Smolin, Susana Roselló-Keränen, Christin Habigt, Daniel Marbach, Christophe Boetsch, David Dejardin, Nassim Sleiman, Stefan Evers, Muriel Richard, Caroline Ardeshir, Jehad Charo, Anton Kraxner, Volker Teichgräber, Nino Keshelava, Rafal Dziadziuszko

    Published in EBioMedicine (2024-11-01)
    Get full text
    Article


  6. 6

    PCM4EU and PRIME-ROSE: Collaboration for implementation of precision cancer medicine in Europe by Kjetil Taskén, Soemeya F. Haj Mohammad, Gro Live Fagereng, Ragnhild Sørum Falk, Åslaug Helland, Sahar Barjesteh van Waalwijk van Doorn-Khosrovani, Katarina Steen Carlsson, Bettina Ryll, Katriina Jalkanen, Anders Edsjö, Hege G. Russnes, Ulrik Lassen, Ebba Hallersjö Hult, Iwona Lugowska, Jean-Yves Blay, Loic Verlingue, Edvard Abel, Maeve A. Lowery, Matthew G. Krebs, Kristoffer Staal Rohrberg, Kristiina Ojamaa, Julio Oliveira, Henk M.W. Verheul, Emile E. Voest, Hans Gelderblom

    Published in Acta Oncologica (2024-05-01)
    Get full text
    Article


Search Tools: